Blackrock’s Sending THIS Crypto Higher on Purpose

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

Kishor Peter Soparkar net worth and biography

Kishor Soparkar Biography and Net Worth

Insider of Adverum Biotechnologies

Kishor Peter Soparkar is Adverum’s chief operating officer, responsible for leading the human resources, AD/QC/QA, clinical operations, legal, information technology, and facilities. Mr. Soparkar has 20 years of experience, including corporate development, corporate governance, legal, regulatory, commercial, and public compliance activities, for biotechnology companies as well as at a leading international law firm. Previously, Mr. Soparkar was chief legal officer and head of human resources at Counsyl, Inc., where he also served as corporate secretary and head of compliance. Earlier, Mr. Soparkar was at Jazz Pharmaceuticals for ten years, where he led the legal team’s support of company operations and other business matters, including delivering on numerous debt and equity financings and four landmark transactions. Earlier in his career, Mr. Soparkar worked at Latham & Watkins in London and San Francisco, with a practice spanning international and domestic markets, as well as private and public transactions. He earned a J.D. from New York University and a B.A. in economics and politics from Oberlin College.

What is Kishor Peter Soparkar's net worth?: The estimated net worth of Kishor Peter Soparkar is at least $164,054.13 as of March 15th, 2023. Mr. Soparkar owns 26,589 shares of Adverum Biotechnologies stock worth more than $164,054 as of November 21st. This net worth evaluation does not reflect any other investments that Mr. Soparkar may own. Additionally, Mr. Soparkar receives a salary of $674,980.00 as Insider at Adverum Biotechnologies. Learn More about Kishor Peter Soparkar's net worth.
How old is Kishor Peter Soparkar?: Mr. Soparkar is currently 53 years old. There are 6 older executives and no younger executives at Adverum Biotechnologies. The oldest executive at Adverum Biotechnologies is Mr. John W. Rakow J.D., Senior VP & General Counsel, who is 67 years old. Learn More on Kishor Peter Soparkar's age.
What is Kishor Peter Soparkar's salary?: As the Insider of Adverum Biotechnologies, Inc., Mr. Soparkar earns $674,980.00 per year. There are 3 executives that earn more than Mr. Soparkar. The highest earning executive at Adverum Biotechnologies is Dr. Laurent Fischer, President, CEO & Director, who commands a salary of $1,020,000.00 per year. Learn More on Kishor Peter Soparkar's salary.
How do I contact Kishor Peter Soparkar?: The corporate mailing address for Mr. Soparkar and other Adverum Biotechnologies executives is 800 Saginaw Drive, Redwood City CA, 94063. Adverum Biotechnologies can also be reached via phone at (650) 656-9323 and via email at [email protected]. Learn More on Kishor Peter Soparkar's contact information.
Has Kishor Peter Soparkar been buying or selling shares of Adverum Biotechnologies?: Kishor Peter Soparkar has not been actively trading shares of Adverum Biotechnologies during the last ninety days. Most recently, Peter Soparkar sold 1,336 shares of the business's stock in a transaction on Wednesday, March 15th. The shares were sold at an average price of $7.80, for a transaction totalling $10,420.80. Following the completion of the sale, the chief operating officer now directly owns 26,589 shares of the company's stock, valued at $207,394.20. Learn More on Kishor Peter Soparkar's trading history.
Who are Adverum Biotechnologies' active insiders?: Adverum Biotechnologies' insider roster includes Julie Clark (Insider), Laurent Fischer (CEO), James Scopa (Director), and Kishor Soparkar (Insider). Learn More on Adverum Biotechnologies' active insiders.
Are insiders buying or selling shares of Adverum Biotechnologies?: During the last year, Adverum Biotechnologies insiders bought shares 3 times. They purchased a total of 231,346 shares worth more than $1,798,951.50. The most recent insider tranaction occured on July, 30th when Major Shareholder Braden Michael Leonard bought 85,800 shares worth more than $613,470.00. Insiders at Adverum Biotechnologies own 4.2% of the company. Learn More about insider trades at Adverum Biotechnologies.
Information on this page was last updated on 7/30/2024.

Kishor Peter Soparkar Insider Trading History at Adverum Biotechnologies

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/15/2023	Sell	1,336	$7.80	$10,420.80	26,589
4/19/2022	Buy	2,192	$11.40	$24,988.80	28,055
12/8/2021	Buy	2,500	$19.10	$47,750.00
8/17/2020	Buy	769	$130.00	$99,970.00	769

Kishor Peter Soparkar Buying and Selling Activity at Adverum Biotechnologies

Adverum Biotechnologies Company Overview

Adverum Biotechnologies, Inc., a clinical-stage company, develops gene therapy product candidates to treat ocular diseases. Its lead product candidate is ixoberogene soroparvovec (ADVM-022), a single intravitreal injection gene therapy candidate used for the treatment of patients with wet age-related macular degeneration and diabetic macular edema which is in phase 2 clinical trials. The company is developing ADVM-062 (AAV.7m8-L-opsin), a novel gene therapy product candidate for the treatment of blue cone monochromacy via a single IVT injection. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; GenSight Biologics; Lexeo Therapeutics; and Virovek, Inc. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California.

Today's Range

Now: $6.17

$6.00

$6.34

50 Day Range

MA: $7.46

$6.25

$8.48

2 Week Range

Now: $6.17

$6.00

$29.70

Volume

221,338 shs

Average Volume

277,283 shs

Market Capitalization

$128.34 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.02

Blackrock’s Sending THIS Crypto Higher on Purpose

From Crypto 101 Media | Ad

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

YES, I WANT THE #1 CRYPTO NOW

Kishor Soparkar Biography and Net Worth

What is Kishor Peter Soparkar's net worth?

How old is Kishor Peter Soparkar?

What is Kishor Peter Soparkar's salary?

How do I contact Kishor Peter Soparkar?

Has Kishor Peter Soparkar been buying or selling shares of Adverum Biotechnologies?

Who are Adverum Biotechnologies' active insiders?

Are insiders buying or selling shares of Adverum Biotechnologies?